Related Experiment Video
Updated: Jul 16, 2026

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
Therapeutic use of erythropoietin in dermatooncology
Imke Satzger1, Florian Schenck, Felicitas Thol
1Department of Dermatology and Venereology, Skin Tumor Center, Hannover Medical School, Hannover, Germany. satzger.imke@mh-hannover.de
Abstract:
Erythropoietin has been successfully used in Europe since 1997 in the treatment of anemia induced by chemotherapy of solid tumors. There is only limited experience with regard to its use when treating dermatologic tumors such as metastatic melanoma. We review here current guidelines on the use of erythropoietin in cancer patients and report on our own melanoma patients treated with erythropoietin for chemotherapy-induced anemia.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Mitogens and the Cell Cycle
Erythropoiesis
Erythropoiesis
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
